RxDoctor Payments Data

Andrew Oh, MD

Pain Medicine · Portland, ORNPI 1932312766

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Vertiflex, Inc. at 58.3% of the total. Reporting peaked in 2019 at $18,698 and has fallen 89.5% since, to $1,965 in 2025. Among pain medicine clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,103in general payments, 2019–2025

Across 313 payments — averaging $96.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertiflex, Inc.$18K
  • Abbott$4K
  • Spinal Simplicity, LLC$2K
  • Si-bone, Inc.$2K
  • Boston Scientific$863
  • Aurora Spine, Inc.$793
  • plus $4K from 29 others
$5,700in research payments, 2019–2025

Across 1 payment — averaging $5700.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertiflex, Inc.$6K

What the payments were for

  • Speaking & faculty fees$15,50051%
  • Travel & lodging$4,32414%
  • Food & beverage$8,22127%
  • Education$1,6135%
  • Entertainment$4451%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,103 in reported general payments places this provider in the 90th percentile of 57 pain medicine providers in Oregon.

See all pain medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$198,708
Medicare patients
419
Services billed
3,556

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl11$4,700
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen171$3,896
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen145$3,262
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl38$3,125
Buprenorphine Hcl90$3,061
Oxycodone Hcl181$2,915
Duloxetine Hcl164$2,891
Gabapentin184$2,613
Pregabalin118$2,015
Morphine Sulfate ErMorphine Sulfate73$1,912
Tizanidine Hcl120$1,693
Celecoxib36$1,440
Cyclobenzaprine Hcl55$1,113
Fentanyl15$1,012
Tramadol Hcl ErTramadol Hcl12$796

Paid to pharmacies, not to this prescriber.

Other pain medicine in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →